The Latest Breaking News on Pharma

Abbott topped Wall Street's fourth-quarter expectations Wednesday, helped by already declining Covid test sales, and ABT stock drooped.

Amid rising demand and government investments, the biotech industry is poised to witness significant growth in the foreseeable future. Given this backdrop, quality biotech stock Gilead Sciences (GILD) might be a wise addition to your portfolio this January. However, Stoke Therapeutics (STOK) could be best avoided, given its bleak fundamentals.…

Anne McElvoy finds rejuvenation and fresh skin at two of the capital’s best facialists

Documentary follows Goldin, the artist who became addicted to OxyContin, as she confronts the wealthy art patrons who profited from its sale

Stéphane Bancel, the chief executive of drug company Moderna, could barely restrain his pride in issuing his annual letter to shareholders on Jan. 3.

Amazon is adding generic medications to the list of goods and services it offers. How will that impact its revenue and share price?.

South Dakota Gov. Kristi Noem, along with the state’s Republican attorney general, say the state will prosecute pharmacists who dispense abortion-inducing pills

The European Union's drug regulator needs to do more to tackle shortages of some widely-used antibiotics in the region, according to a letter from a group of European patient and consumer organisations reviewed by Reuters on Tuesday.

Suspected drug death figures are based on Police Scotland information not confirmed through toxicology.

Covid vaccines took a major toll on Johnson & Johnson and Danaher early Tuesday, hitting J&J's fourth-quarter sales and Danaher's guidance.

President Vladimir Putin said on Tuesday that there were shortages of some medicines in Russia, despite the country producing more of its own drugs, and suggested building up stocks of popular medicines to help meet demand.